Post written by Joseph D. Feuerstein, MD, from the Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. The focus of this study was to assess the benefits of adding chromoendoscopy to enhance our ability to screen for colorectal cancer in patients with longstanding inflammatory bowel disease affecting …
Continue reading Chromoendoscopy versus white-light endoscopy in patients with IBD
GIE Senior Associate Editor, Dr. John R. Saltzman, MD, highlights this article from the February issue “Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group” by Bo Shen, MD, et al. There is an increasing recognition that Interventional (or therapeutic) inflammatory bowel disease …
Post written by Bo Shen, MD, from the Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USA. The team from the Global Interventional IBD (Gi-IBD) group and ASGE Special Interest Group in Interventional IBD put together a position statement on endoscopic management of structural and neoplastic complications of IBD. With better understanding of etiology, …
Continue reading Role of interventional inflammatory bowel disease in the era of biologic therapy
Post written by Gursimran Kochhar, MD, from the Mayo Clinic, Jacksonville, Florida. Fistulas indicate one advanced disease phenotype in patients with IBD. Currently, there is no definitive therapy for management of fistulas. Medical therapy is not adequate, and surgical therapy forms the cornerstone of management of fistulas in patients with IBD. Although surgical therapy is …
Continue reading Endoscopic fistulotomy in inflammatory bowel disease
Post written by Bo Shen, MD, FASGE, from the Interventional IBD Unit, the Cleveland Clinic Foundation, Cleveland, Ohio. Treatment of disease-related or surgery-related Crohn’s fistula, abscess, and surgical anastomotic leaks with endoscopy-guided fistulotomy and sinusotomy with electroincision, seton placement, through-the-scope or over-the-scope clipping, suturing, incision and drainage. Crohn’s disease has 3 phenotypes: inflammatory, structuring, and …
Continue reading Endoscopic therapy for Crohn’s fistula and abscess
Post written by Markus F. Neurath, MD, from the Medical Clinic 1, Department of Medicine, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany. The introduction of mucosal healing as a key therapeutic goal in IBD patients has highlighted the importance of endoscopy for therapeutic monitoring. Additionally, endoscopy plays a crucial role in cancer surveillance in …
Parakkal Deepak, MBBS, from the Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, in Rochester, Minnesota, USA discusses "Incremental diagnostic yield of chromoendoscopy and outcomes in inflammatory bowel disease patients with a history of colorectal dysplasia on white-light endoscopy." The focus of our study was to evaluate whether initial and subsequent chromoendoscopy (CE) …
Continue reading Incremental diagnostic yield of chromoendoscopy in IBD
GIE Associate Editor Alessandro Repici, MD, recommends this article from the May issue "The role of endoscopy in inflammatory bowel disease" from the ASGE Standards of Practice committee, Amandeep K. Shergill, Jenifer R. Lightdale, David H. Bruining, et al. This is a valuable study because it is an excellent update on how endoscopy should be used …
Associate Editor Dr. Seth Gross highlights this article “SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease” by Loren Laine, MD, Tonya Kaltenbach, MD, Alan Barkun, MD, Kenneth R. McQuaid, MD, Venkataraman Subramanian, MD, and Roy Soetikno, MD for the SCENIC Guideline Development Panel as March’s Editor’s Choice. The article …
Continue reading Editor’s Choice- Consensus statement on dysplasia in IBD
